Thursday, 18 Oct 2018

You are here

Dr. Rachel Tate: Adalimumab and Disease Remission in non-Radiographic Axial SpA

Dr. Rachel Tate discusses the ABILITY 3 study at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Carol Langford: MOC resources

09 Nov 2015

RWCS 2017: Biosimilars

21 Feb 2017

Dr. Arthur Kavanaugh: Biosimilars and...

30 Jan 2017

The ACR17 RheumNow Week in Review - 10...

10 Nov 2017

Christopher Ritchlin, MD: exciting data...

12 Nov 2015

4 Contraindications to TNF Inhibitor Use

03 Oct 2016

RheumNow Week in Review – 30 September...

30 Sep 2016

The RheumNow Week in Review - 15...

15 Dec 2017

Dr. Peter Lipsky at EULAR 2018-...

15 Jun 2018

Dr. Paul Sufka: Pregnancy and Treatment

07 Nov 2017

Dr. Uma Mahadevan: Gastroenterology...

11 Feb 2018

The RheumNow Week in Review – Lupus in...

27 Jul 2018